Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|November 26, 2013

Almac Launches Logistics Support Services

Almac releases an enhanced third-party logistics customer billing application.

Almac has released an improved third-party logistics (3PL) customer- billing application.

In response to client demand for end-to-end support of EU product launches, from import testing, country specific packaging, QP release, online ordering, direct to pharmacy distribution, and financial services, Almac have improved their customer billing software to facilitate an invoicing process on behalf of 3PL clients.

3PL orders, received directly from hospitals, clinics, and pharmacies for niche/orphan drug products, will now be processed, dispatched, and automatically invoiced on the client’s behalf. The process will be completed by reconciliation of payments to the client’s EU account, as well as debtor follow-up.

Source: Almac


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.